Espinal, P <br/><br/>
First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Jan 2013 
 - 589-91 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.01157-12  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acinetobacter Infections--drug therapy<br/>Acinetobacter baumannii--drug effects<br/>Anti-Bacterial Agents--pharmacology<br/>Bacterial Typing Techniques<br/>Carbapenems--pharmacology<br/>Chromosomes, Bacterial<br/>DNA Transposable Elements<br/>Electrophoresis, Gel, Pulsed-Field<br/>Humans<br/>Male<br/>Microbial Sensitivity Tests<br/>Middle Aged<br/>Spain<br/>beta-Lactam Resistance--genetics<br/>beta-Lactamases--genetics